Utility of Serum Procalcitonin for Diagnosis of Sepsis and Evaluation of Severity.
- Author:
Taejin PARK
1
;
Chae Man LIM
;
Younsuck KOH
;
Sang Bum HONG
Author Information
- Publication Type:Original Article
- Keywords: Sepsis; Biomarkers; Procalcitonin; Diagnosis
- MeSH: Biomarkers; Calcitonin; Humans; Intensive Care Units; Protein Precursors; Retrospective Studies; Sepsis; Shock; Shock, Septic
- From:Tuberculosis and Respiratory Diseases 2011;70(1):51-57
- CountryRepublic of Korea
- Language:Korean
- Abstract: BACKGROUND: Early recognition and treatment of sepsis would improve patients' outcome. But it is difficult to distinguish between sepsis and non-infectious conditions in the acute phase of clinical deterioration. We studied serum level of procalcitonin (PCT) as a method to diagnose and to evaluate sepsis. METHODS: Between 1 March 2009 and 30 September 2009, 178 patients had their serum PCT tested during their clinical deterioration in the medical intensive care unit. These laboratories were evaluated, on a retrospective basis. We classified their clinical status as non-infection, local infection, sepsis, severe sepsis, and septic shock. Then, we compared their clinical status with level of PCT. RESULTS: The number of clinical status is as follows: 18 non-infection, 33 local infection, 39 sepsis, 26 severe sepsis, and 62 septic shock patients. PCT level of non-septic group (non-infection and local infection) and septic group (sepsis, severe sepsis, septic shock) was 0.36+/-0.57 ng/mL and 18.09+/-36.53 ng/mL (p<0.001), respectively. Area under the curve for diagnosis of sepsis using cut-off value of PCT >0.5 ng/mL was 0.841 (p<0.001). Level of PCT as clinical status was statistically different between severe sepsis and septic shock (*severe sepsis; 4.53+/-6.15 ng/mL, *septic shock 34.26+/-47.10 ng/mL, *p<0.001). CONCLUSION: Level of PCT at clinical deterioration showed diagnostic power for septic condition. The level of PCT was statistically different between severe sepsis and septic shock.
